SU382287A3 - - Google Patents

Info

Publication number
SU382287A3
SU382287A3 SU1451402A SU1451402A SU382287A3 SU 382287 A3 SU382287 A3 SU 382287A3 SU 1451402 A SU1451402 A SU 1451402A SU 1451402 A SU1451402 A SU 1451402A SU 382287 A3 SU382287 A3 SU 382287A3
Authority
SU
USSR - Soviet Union
Application number
SU1451402A
Other languages
Russian (ru)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB5013069A external-priority patent/GB1260886A/en
Application filed filed Critical
Application granted granted Critical
Publication of SU382287A3 publication Critical patent/SU382287A3/ru

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/53751,4-Oxazines, e.g. morpholine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D265/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/281,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/301,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
SU1451402A 1969-10-13 1970-06-18 SU382287A3 (enExample)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB5013069A GB1260886A (en) 1969-06-20 1969-06-20 Process for aryloxymethylmorpholine derivatives

Publications (1)

Publication Number Publication Date
SU382287A3 true SU382287A3 (enExample) 1973-05-22

Family

ID=10454773

Family Applications (1)

Application Number Title Priority Date Filing Date
SU1451402A SU382287A3 (enExample) 1969-10-13 1970-06-18

Country Status (5)

Country Link
CS (1) CS167901B2 (enExample)
DK (1) DK143399C (enExample)
PL (1) PL88898B1 (enExample)
SE (1) SE408419B (enExample)
SU (1) SU382287A3 (enExample)

Also Published As

Publication number Publication date
PL88898B1 (enExample) 1976-10-30
DK143399C (da) 1981-12-21
CS167901B2 (enExample) 1976-05-28
DK143399B (da) 1981-08-17
SE7605248L (sv) 1976-05-07
SE408419B (sv) 1979-06-11

Similar Documents

Publication Publication Date Title
AU2270770A (enExample)
AU465452B2 (enExample)
AU429630B2 (enExample)
AU450150B2 (enExample)
AU442375B2 (enExample)
AU2355770A (enExample)
AU470301B1 (enExample)
AU427401B2 (enExample)
AU442538B2 (enExample)
AU442554B2 (enExample)
AU428129B2 (enExample)
AU470661B1 (enExample)
AU428131B2 (enExample)
AU442285B2 (enExample)
AU442322B2 (enExample)
AU442357B2 (enExample)
AU428074B2 (enExample)
AU442380B2 (enExample)
AU442463B2 (enExample)
AU442535B2 (enExample)
AT308690B (enExample)
AU410358B2 (enExample)
AU414607B2 (enExample)
AU417208B2 (enExample)
AU5228269A (enExample)